Jim Simons's position in Voyager Therapeutics is currently worth $1.4 Million. That's 0.00% of their equity portfolio (2080th largest holding). The first Voyager Therapeutics trade was made in Q2 2017. Since then Jim Simons bought shares fourteen more times and sold shares on twelve occasions. The investor's estimated purchase price is $1.63 Million, resulting in a loss of 14%.